Cargando…

An observational study of adult admissions to a medical ICU due to adverse drug events

BACKGROUND: The objectives of the study were to estimate the incidence of intensive care unit (ICU) admissions due to adverse drug events (ADEs), to assess preventability, severity and costs of the corresponding ADE and to determine the leading causes of preventable ADEs. METHODS: An observational s...

Descripción completa

Detalles Bibliográficos
Autores principales: Jolivot, Pierre-Alain, Pichereau, Claire, Hindlet, Patrick, Hejblum, Gilles, Bigé, Naïke, Maury, Eric, Guidet, Bertrand, Fernandez, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Paris 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735088/
https://www.ncbi.nlm.nih.gov/pubmed/26830112
http://dx.doi.org/10.1186/s13613-016-0109-9
_version_ 1782413014619652096
author Jolivot, Pierre-Alain
Pichereau, Claire
Hindlet, Patrick
Hejblum, Gilles
Bigé, Naïke
Maury, Eric
Guidet, Bertrand
Fernandez, Christine
author_facet Jolivot, Pierre-Alain
Pichereau, Claire
Hindlet, Patrick
Hejblum, Gilles
Bigé, Naïke
Maury, Eric
Guidet, Bertrand
Fernandez, Christine
author_sort Jolivot, Pierre-Alain
collection PubMed
description BACKGROUND: The objectives of the study were to estimate the incidence of intensive care unit (ICU) admissions due to adverse drug events (ADEs), to assess preventability, severity and costs of the corresponding ADE and to determine the leading causes of preventable ADEs. METHODS: An observational study was conducted in a medical ICU of a teaching hospital from February 2013 to February 2014. RESULTS: A total of 743 consecutive admissions were included, and they involved 701 different patients. The included admissions were categorized into three groups (admissions due to preventable ADE, admissions due to unpreventable ADE and the control group). Among the 743 ICU admissions included during the study period, 173 (23.3 %) were due to ADE, with 102 (13.7 %) related to preventable ADE and 71 (9.6 %) to unpreventable ADE, yielding a preventability rate of ADE of 0.59 (102/173). Admissions due to unpreventable ADE concerned patients with more comorbidities, a greater number of drugs and higher Simplified Acute Physiology Score II than admissions due to preventable ADE and the control group admissions (n = 570). Hospital mortality rates, corresponding costs and length of stay were all similar in the preventable ADE and control groups, whereas they were always significantly higher in the unpreventable ADE group. ICU mortality, length of stay and the corresponding costs were similar in the three groups. Non-compliance was the principal leading cause of preventable ADE (n = 31/102). The 102 preventable ADE-related admissions accounted for a total of 528 days of hospitalization in the ICU, requiring a mean of 1.4 ICU beds per day over the one-year period, with an associated total cost amounting to 747,651 €. CONCLUSIONS: ADE was a major cause of admission in the studied ICU, and in 59 % of the cases, ADEs were preventable. The reported burden of ICU admissions due to ADE advocates for further investigations to explore how the rate of such admissions could be decreased. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13613-016-0109-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4735088
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Paris
record_format MEDLINE/PubMed
spelling pubmed-47350882016-02-12 An observational study of adult admissions to a medical ICU due to adverse drug events Jolivot, Pierre-Alain Pichereau, Claire Hindlet, Patrick Hejblum, Gilles Bigé, Naïke Maury, Eric Guidet, Bertrand Fernandez, Christine Ann Intensive Care Research BACKGROUND: The objectives of the study were to estimate the incidence of intensive care unit (ICU) admissions due to adverse drug events (ADEs), to assess preventability, severity and costs of the corresponding ADE and to determine the leading causes of preventable ADEs. METHODS: An observational study was conducted in a medical ICU of a teaching hospital from February 2013 to February 2014. RESULTS: A total of 743 consecutive admissions were included, and they involved 701 different patients. The included admissions were categorized into three groups (admissions due to preventable ADE, admissions due to unpreventable ADE and the control group). Among the 743 ICU admissions included during the study period, 173 (23.3 %) were due to ADE, with 102 (13.7 %) related to preventable ADE and 71 (9.6 %) to unpreventable ADE, yielding a preventability rate of ADE of 0.59 (102/173). Admissions due to unpreventable ADE concerned patients with more comorbidities, a greater number of drugs and higher Simplified Acute Physiology Score II than admissions due to preventable ADE and the control group admissions (n = 570). Hospital mortality rates, corresponding costs and length of stay were all similar in the preventable ADE and control groups, whereas they were always significantly higher in the unpreventable ADE group. ICU mortality, length of stay and the corresponding costs were similar in the three groups. Non-compliance was the principal leading cause of preventable ADE (n = 31/102). The 102 preventable ADE-related admissions accounted for a total of 528 days of hospitalization in the ICU, requiring a mean of 1.4 ICU beds per day over the one-year period, with an associated total cost amounting to 747,651 €. CONCLUSIONS: ADE was a major cause of admission in the studied ICU, and in 59 % of the cases, ADEs were preventable. The reported burden of ICU admissions due to ADE advocates for further investigations to explore how the rate of such admissions could be decreased. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13613-016-0109-9) contains supplementary material, which is available to authorized users. Springer Paris 2016-02-02 /pmc/articles/PMC4735088/ /pubmed/26830112 http://dx.doi.org/10.1186/s13613-016-0109-9 Text en © Jolivot et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Research
Jolivot, Pierre-Alain
Pichereau, Claire
Hindlet, Patrick
Hejblum, Gilles
Bigé, Naïke
Maury, Eric
Guidet, Bertrand
Fernandez, Christine
An observational study of adult admissions to a medical ICU due to adverse drug events
title An observational study of adult admissions to a medical ICU due to adverse drug events
title_full An observational study of adult admissions to a medical ICU due to adverse drug events
title_fullStr An observational study of adult admissions to a medical ICU due to adverse drug events
title_full_unstemmed An observational study of adult admissions to a medical ICU due to adverse drug events
title_short An observational study of adult admissions to a medical ICU due to adverse drug events
title_sort observational study of adult admissions to a medical icu due to adverse drug events
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735088/
https://www.ncbi.nlm.nih.gov/pubmed/26830112
http://dx.doi.org/10.1186/s13613-016-0109-9
work_keys_str_mv AT jolivotpierrealain anobservationalstudyofadultadmissionstoamedicalicuduetoadversedrugevents
AT pichereauclaire anobservationalstudyofadultadmissionstoamedicalicuduetoadversedrugevents
AT hindletpatrick anobservationalstudyofadultadmissionstoamedicalicuduetoadversedrugevents
AT hejblumgilles anobservationalstudyofadultadmissionstoamedicalicuduetoadversedrugevents
AT bigenaike anobservationalstudyofadultadmissionstoamedicalicuduetoadversedrugevents
AT mauryeric anobservationalstudyofadultadmissionstoamedicalicuduetoadversedrugevents
AT guidetbertrand anobservationalstudyofadultadmissionstoamedicalicuduetoadversedrugevents
AT fernandezchristine anobservationalstudyofadultadmissionstoamedicalicuduetoadversedrugevents
AT jolivotpierrealain observationalstudyofadultadmissionstoamedicalicuduetoadversedrugevents
AT pichereauclaire observationalstudyofadultadmissionstoamedicalicuduetoadversedrugevents
AT hindletpatrick observationalstudyofadultadmissionstoamedicalicuduetoadversedrugevents
AT hejblumgilles observationalstudyofadultadmissionstoamedicalicuduetoadversedrugevents
AT bigenaike observationalstudyofadultadmissionstoamedicalicuduetoadversedrugevents
AT mauryeric observationalstudyofadultadmissionstoamedicalicuduetoadversedrugevents
AT guidetbertrand observationalstudyofadultadmissionstoamedicalicuduetoadversedrugevents
AT fernandezchristine observationalstudyofadultadmissionstoamedicalicuduetoadversedrugevents